Alonso-Villaverde C - Search Results

1

[Clinical manifestations of familial hypercholesterolemia in Mediterranean population].

Alonso-Villaverde C, Sardà P, Vallbé JC, Heras M, Pérez-Jiménez F, Pedro-Botet JC, Ros-Rahola E, Masana L. Alonso-Villaverde C, et al. Med Clin (Barc). 1999 Oct 30;113(14):521-5. Med Clin (Barc). 1999. PMID: 10605666 Spanish.

2

[Micronutrients in HIV-infection and the relationship with the inflammatory response].

Jiménez-Expósito MJ, Bulló Bonet M, Alonso-Villaverde C, Serrano P, García-Lorda P, García-Luna PP, Masana L, Salas-Salvadó J. Jiménez-Expósito MJ, et al. Med Clin (Barc). 2002 Dec 7;119(20):765-9. Med Clin (Barc). 2002. PMID: 12525309 Spanish.

3

The efavirenz-induced increase in HDL-cholesterol is influenced by the multidrug resistance gene 1 C3435T polymorphism.

Alonso-Villaverde C, Coll B, Gómez F, Parra S, Camps J, Joven J, Masana L. Alonso-Villaverde C, et al. AIDS. 2005 Feb 18;19(3):341-2. AIDS. 2005. PMID: 15718846

4

The stromal derived factor-1 mutated allele (SDF1-3'A) is associated with a lower incidence of atherosclerosis in HIV-infected patients.

Coll B, Alonso-Villaverde C, Parra S, Montero M, Tous M, Joven J, Masana L. Coll B, et al. AIDS. 2005 Nov 4;19(16):1877-83. doi: 10.1097/01.aids.0000183516.22266.dd. AIDS. 2005. PMID: 16227796

5

Protease inhibitor-associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T->C gene variation.

Guardiola M, Ferré R, Salazar J, Alonso-Villaverde C, Coll B, Parra S, Masana L, Ribalta J. Guardiola M, et al. Clin Chem. 2006 Oct;52(10):1914-9. doi: 10.1373/clinchem.2006.069583. Epub 2006 Aug 3. Clin Chem. 2006. PMID: 16887900

6

Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection.

Parra S, Alonso-Villaverde C, Coll B, Ferré N, Marsillach J, Aragonès G, Mackness M, Mackness B, Masana L, Joven J, Camps J. Parra S, et al. Atherosclerosis. 2007 Sep;194(1):175-81. doi: 10.1016/j.atherosclerosis.2006.07.024. Epub 2006 Aug 30. Atherosclerosis. 2007. PMID: 16942773

7

[Cholestasis caused by captopril].

Alonso-Villaverde C, Ubiría J, Masana L, Prats E. Alonso-Villaverde C, et al. Med Clin (Barc). 1992 Nov 7;99(15):595. Med Clin (Barc). 1992. PMID: 1460917 Spanish. No abstract available.

8

The fatty acid binding protein-4 (FABP4) is a strong biomarker of metabolic syndrome and lipodystrophy in HIV-infected patients.

Coll B, Cabre A, Alonso-Villaverde C, Lazaro I, Aragonés G, Parra S, Girona J, Masana L. Coll B, et al. Atherosclerosis. 2008 Jul;199(1):147-53. doi: 10.1016/j.atherosclerosis.2007.09.032. Epub 2007 Nov 5. Atherosclerosis. 2008. PMID: 17983623

9

High-density lipoprotein concentrations relate to the clinical course of HIV viral load in patients undergoing antiretroviral therapy.

Alonso-Villaverde C, Segues T, Coll-Crespo B, Pérez-Bernalte R, Rabassa A, Gomila M, Parra S, Gozález-Esteban MA, Jiménez-Expósito MJ, Masana L. Alonso-Villaverde C, et al. AIDS. 2003 May 23;17(8):1173-8. doi: 10.1097/00002030-200305230-00009. AIDS. 2003. PMID: 12819519

10

Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele.

Alonso-Villaverde C, Coll B, Parra S, Montero M, Calvo N, Tous M, Joven J, Masana L. Alonso-Villaverde C, et al. Circulation. 2004 Oct 12;110(15):2204-9. doi: 10.1161/01.CIR.0000143835.95029.7D. Epub 2004 Oct 4. Circulation. 2004. PMID: 15466648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters